189 related articles for article (PubMed ID: 25376382)
21. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients.
Box B; Lindsey I; Wheeler JM; Warren BF; Cunningham C; George BD; Mortensen NJ; Jones AC
Dis Colon Rectum; 2005 Jun; 48(6):1153-60. PubMed ID: 15868236
[TBL] [Abstract][Full Text] [Related]
23. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy.
Williamson JS; Jones HG; Davies M; Evans MD; Hatcher O; Beynon J; Harris DA;
Br J Surg; 2014 Sep; 101(10):1290-8. PubMed ID: 24924947
[TBL] [Abstract][Full Text] [Related]
25. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
26. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy.
Rosati R; Bona S; Romario UF; Elmore U; Furlan N
Surg Oncol; 2007 Dec; 16 Suppl 1():S83-9. PubMed ID: 18042378
[TBL] [Abstract][Full Text] [Related]
28. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
29. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
30. [Rectal cancer surgery in Germany - a 10-year-analysis based on the data of the "Institute of Quality Assurance in Operative Medicine" at the Otto-von-Guericke University Magdeburg].
Ptok H; Mundt A; Lippert H; Gastinger I
Zentralbl Chir; 2013 Aug; 138(4):418-26. PubMed ID: 23733243
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Maeda K; Shibutani M; Tachimori A; Nishii T; Aomatsu N; Fukuoka T; Nagahara H; Otani H; Inoue T; Ohira M
In Vivo; 2020; 34(1):283-289. PubMed ID: 31882490
[TBL] [Abstract][Full Text] [Related]
32. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
33. The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection.
Brandt WS; Yong S; Abood G; Micetich K; Walther A; Shoup M
Am J Surg; 2014 Mar; 207(3):357-60; discussion 360. PubMed ID: 24456833
[TBL] [Abstract][Full Text] [Related]
34. Quality assurance in rectal cancer treatment.
van de Velde CJ; van den Broek CB
Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
[TBL] [Abstract][Full Text] [Related]
35. Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.
van Erning FN; Rutten HJ; van den Berg HA; Lemmens VE; van Halteren HK
Eur J Surg Oncol; 2015 Dec; 41(12):1630-5. PubMed ID: 26437853
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
[TBL] [Abstract][Full Text] [Related]
37. Local excision of rectal cancer followed by radical surgery because of poor prognostic features does not compromise the long term oncologic outcome.
Gagliardi G; Newton TR; Bailey HR
Colorectal Dis; 2013 Nov; 15(11):e659-64. PubMed ID: 24033889
[TBL] [Abstract][Full Text] [Related]
38. Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer.
Benzoni E; Terrosu G; Bresadola V; Cerato F; Cojutti A; Milan E; Dado G; Bresadola F
Eur J Cancer Care (Engl); 2006 Jul; 15(3):286-92. PubMed ID: 16882126
[TBL] [Abstract][Full Text] [Related]
39. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
40. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
